###begin article-title 0
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells
###end article-title 0
###begin p 1
###xml 34 57 34 57 <email xmlns:xlink="http://www.w3.org/1999/xlink">tak24@igm.hokudai.ac.jp</email>
CORRESPONDENCE Takashi Nishimura: tak24@igm.hokudai.ac.jp
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 184 185 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 418 419 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 475 476 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1017 1018 1017 1018 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1090 1091 1090 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1118 1121 1118 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1300 1301 1300 1301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
We propose a novel role for interleukin (IL) 6 in inducing rapid spontaneous proliferation (SP) of naive CD8+ T cells, which is a crucial step in the differentiation of colitogenic CD8+ T cells. Homeostasis of T cells is regulated by two distinct modes of cell proliferation: major histocompatibility complex/antigen-driven rapid SP and IL-7/IL-15-dependent slow homeostatic proliferation. Using our novel model of CD8+ T cell-dependent colitis, we found that SP of naive CD8+ T cells is essential for inducing pathogenic cytokine-producing effector T cells. The rapid SP was predominantly induced in mesenteric lymph nodes (LNs) but not in peripheral LNs under the influence of intestinal flora and IL-6. Indeed, this SP was markedly inhibited by treatment with anti-IL-6 receptor monoclonal antibody (IL-6R mAb) or antibiotic-induced flora depletion, but not by anti-IL-7R mAb and/or in IL-15-deficient conditions. Concomitantly with the inhibition of SP, anti-IL-6R mAb significantly inhibited the induction of CD8+ T cell-dependent autoimmune colitis. Notably, the transfer of naive CD8+ T cells derived from IL-17-/- mice did not induce autoimmune colitis. Thus, we conclude that IL-6 signaling is crucial for SP under lymphopenic conditions, which subsequently caused severe IL-17-producing CD8+ T cell-mediated autoimmune colitis. We suggest that anti-IL-6R mAb may become a promising strategy for the therapy of colitis.
###end p 3
###begin p 4
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 388 389 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 419 420 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 557 558 557 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 626 627 626 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Homeostasis of T cells can be defined as a mechanism of restoration of immune balance, and maintenance of immune status after T cell depletion or expansion after immunological responses. Homeostasis of T cells is regulated by two distinct modes of cell proliferation: MHC/antigen-driven rapid spontaneous proliferation (SP) and IL-7/IL-15-dependent slow homeostatic proliferation (HP) (1-3). The definition of SP in CD4+ T cell homeostasis was first proposed by Min et al. (1). In this report, we initially propose a crucial role for IL-6 in SP of naive CD8+ T cells for inducing flora-specific colitogenic IL-17-producing CD8+ T (Tc17) cells.
###end p 4
###begin p 5
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 187 188 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
It has been reported that the disruption of the Th1/Th2 immune balance causes various immune diseases (4-8). However, recent discoveries suggested that a new subset of IL-17-producing CD4+ T (Th17) cells, rather than Th1/Th2 cells, might contribute to autoimmune diseases (9-11). Indeed, Th17 cells have been demonstrated to be crucial for inducing experimental autoimmune encephalomyelitis, rheumatoid arthritis, and inflammatory bowel disease (IBD) or colitis (12-16).
###end p 5
###begin p 6
###xml 436 437 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 439 441 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
Idiopathic IBDs, including Crohn's disease and ulcerative colitis, are autoimmune diseases with symptoms including abdominal pain, weight loss, fever, and rectal bleeding. Now, these diseases are thought to be a cytokine-driven inflammation-triggered by excess IL-12/IL-23 and IFN-gamma/IL-17 production for Crohn's disease, and excess type 2 cytokine production, chiefly IL-13, for ulcerative colitis-that affects the large intestine (2, 17).
###end p 6
###begin p 7
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 160 161 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 443 444 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Although studies have addressed the involvement of CD4+ T cells in animal models of IBD (18), there is little information about the possible contribution of CD8+ T cells to the pathogenesis. In this report, we established a novel Tc17 cell-dependent IBD model and initially demonstrated that IL-6-dependent SP of naive CD8+ T cells was essential for the expansion of colitogenic Tc17 cells. Thus, we propose that the control of SP of naive CD8+ T cells by anti-IL-6R mAb will become a novel strategy for developing the therapy for autoimmune diseases.
###end p 7
###begin title 8
RESULTS AND DISCUSSION
###end title 8
###begin title 9
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Adoptive transfer of naive CD8+ T cells causes severe autoimmune colitis
###end title 9
###begin p 10
###xml 64 67 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 289 304 289 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A and B</xref>
###xml 505 506 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 578 586 578 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 705 713 705 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 865 866 865 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1261 1262 1261 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
Severe colitis was induced by a single adoptive transfer of CD44lowCD62L+ naive CD8+ T cells into syngeneic RAG2-/- mice. Transfer of naive CD8+ T cells or CD4+ T cells caused severe weight loss and thickening of the large intestinal wall compared with untreated control mice within 6 wk (Fig. 1, A and B). Hematoxylin-eosin (HE) staining of colon tissue sections revealed large numbers of infiltrating cells, in addition to hemorrhagic necrosis, neoangiogenesis, and depletion of goblet cells, in the CD8+ T cell-transferred mice, which were also assigned histological scores (Fig. 1 C). In addition, elevation of quantitative markers for enteropathy such as serum KC, serum amyloid A (SAA), and ICAM-1 (Fig. 1 D and not depicted) (19, 20) suggested that some inflammatory responses would be induced in the colon. However, it still remained unclear whether the CD8+ T cell-induced pathogenesis was specific to the large intestine. To make this point clear, we examined the induction of pathogenic inflammatory responses in various organs. The pathogenic responses were observed only in the large intestine, and not in other organs such as the liver, kidney, lung, heart, and brain (unpublished data). These pathological events strongly indicated that naive CD8+ T cells could be a critical population for the induction of autoimmune colitis under lymphopenic conditions.
###end p 10
###begin p 11
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Adoptive transfer of naive CD8<sup>+</sup> T cells into RAG2<sup>&#8722;/&#8722;</sup> mice causes severe autoimmune colitis.</bold>
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 123 124 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 188 191 188 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 240 241 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 276 277 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 523 524 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 938 939 937 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1073 1074 1068 1069 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1385 1386 1376 1377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
###xml 1132 1136 <span type="species:ncbi:10090">mice</span>
###xml 1406 1410 <span type="species:ncbi:10090">mice</span>
Adoptive transfer of naive CD8+ T cells into RAG2-/- mice causes severe autoimmune colitis. 5 x 105 CD44lowCD62L+ naive CD8+ T cells from C57BL/6 mice were intravenously injected into RAG2-/- mice. (A) Body weights of untreated (n = 5), CD8+ T cell-transferred (n = 5), or CD4+ T cell-transferred (n = 5) mice were monitored for 6 wk. Percentages of the resultant body weights against preinjection body weights were calculated every week. The means and SDs are indicated. (B) Colon tissues were obtained from control or CD8+ T cell-transferred mice after 9 wk. Morphology of the representative colon tissues is shown. Bar, 1 cm. (C) HE staining was performed on sections of the colon tissues. Histological pictures of the representative tissues are shown at two different magnifications. Means and SDs of the colitis score are indicated in the bar graph. Bars: (left) 1 mm; (right) 200 mum. (D) Serum KC and SAA levels of untreated or CD8+ T cell-transferred mice were measured by ELISA. The means and SDs are indicated. (E) Cytokine (IFN-gamma and IL-17) production by CD8+ T cells from pLNs and mLNs of the adoptively transferred mice 1, 4, and 6 wk after cell transfer. IFN-gamma-producing cells in mLNs or pLNs, and IL-17-producing cells in mLNs or pLNs are indicated. Means and SDs of the percentages of cytokine producing cells are shown. (F) Colon sections from untreated or CD8+ T cell-transferred mice were stained with DAPI, anti-CD8 mAb, and anti-CD11b mAb. Bars, 200 mum.
###end p 11
###begin p 12
###xml 83 84 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 250 258 242 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 335 336 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 357 358 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 438 439 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 447 455 439 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 F</xref>
###xml 481 482 473 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 595 596 587 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 780 781 772 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 833 834 825 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
A kinetics study revealed that IFN-gamma, IL-17, and TNF-alpha were produced by CD8+ T cells, and these cytokine-producing cells preferentially expanded at the mesenteric LNs (mLNs) rather than the peripheral LNs (pLNs) within 1 wk of cell transfer (Fig. 1 E and not depicted). Concomitantly with the increase of cytokine-producing CD8+ T cells in mLNs, CD8+ T cells were infiltrated into colon tissues accompanied with inflammatory CD11b+ cells (Fig. 1 F). Almost all of the CD11b+ cells coexpressed F4/80 macrophage markers (unpublished data). These findings suggest that transferred naive CD8+ T cells would initially be stimulated in the mLNs and then migrate into the peripheral tissues at subsequent pathogenic stages. Thus, it appeared that the rapid expansion of naive CD8+ T cells to generate cytokine-producing effector CD8+ T cells would be closely related with the pathogenesis of autoimmune colitis.
###end p 12
###begin title 13
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Kinetics of SP essential for inducing pathogenic effector memory CD8+ T cells in mLNs
###end title 13
###begin p 14
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 406 407 406 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 425 428 425 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 574 582 574 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 614 615 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 836 837 836 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 883 884 883 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 988 989 988 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1183 1191 1183 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 1388 1389 1388 1389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1462 1465 1462 1465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1472 1480 1472 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 1500 1503 1500 1503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1568 1576 1568 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 1645 1646 1645 1646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1695 1696 1695 1696 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1731 1734 1731 1734 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1857 1865 1857 1865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 2186 2187 2186 2187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2261 2263 2261 2263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 2452 2454 2452 2454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 1420 1435 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1466 1470 <span type="species:ncbi:10090">mice</span>
###xml 1504 1508 <span type="species:ncbi:10090">mice</span>
###xml 1735 1739 <span type="species:ncbi:10090">mice</span>
###xml 2341 2345 <span type="species:ncbi:10090">mice</span>
Recent studies have demonstrated that adoptive transfer of naive T cells into immunodeficient mice resulted in two distinct types of proliferation (1). HP is driven by low-affinity self-MHC/peptide ligands and homeostatic cytokines such as IL-7 and IL-15 (21, 22), whereas SP exhibits rapid and massive proliferation induced by antigen recognition via the TCR (23). After transfer of CFSE-labeled naive CD8+ T cells into RAG2-/- mice, dilution of the cellular fluorescence intensity was analyzed as an index of the cell proliferation at early stages. From a kinetics study (Fig. 2 A), we found that SP of naive CD8+ T cells occurred preferentially in the mLNs rather than in the pLNs within 5 d after the adoptive transfer. This rapid SP was detected neither in pLNs or mLNs at day 3. SP was not detectable in pLNs even at 7 d after CD8+ T cell transfer. At day 7, the numbers of CD8+ T cells collected from the mLNs were much larger than those from the pLNs (Fig. S1, available at ). CD8+ T cells expanded by SP in mLNs but not pLNs, and rapidly acquired more characteristics of a "memory-type" phenotype, such as CD44 markers and a cytokine-producing ability, in the early stages (Fig. 2 B and not depicted). Therefore, these cytokine-producing effector memory cells might be critical for the initiation of colitis. SP in mLNs was not detectable in the following two cases: (a) when CD8+ T cells derived from OT-1-TCR transgenic mice were transferred into RAG2-/- mice (Fig. 2 C), and (b) when RAG2-/- mice were treated with antibiotics to deplete intestinal flora (Fig. 2 D). Moreover, it was demonstrated that SP was different from HP of CD8+ T cells judging from the evidence that naive CD8+ T cells transferred into OT-1/RAG2-/- mice exhibited SP in mLNs, whereas HP was completely blocked in both pLNs and mLNs by endogenously existing OT-1 T cells (Fig. 2 E). Thus, these data clarified that SP, which was triggered with antibiotic-sensitive flora in mLNs via TCR, was distinct from HP induced under the influence of IL-7 and/or IL-15. Alternatively, SP was not an HP-related end stage of T cell proliferation. A previous report had indicated that adoptive transfer of naive CD8+ T cells into lymphopenic hosts elicited no pathology, including colitis (24). This might be because of the strain differences between C57BL/6 and BALB/c mice, which have genetically different predispositions in controlling their susceptibility to immune diseases (25), including our established colitis model (unpublished data).
###end p 14
###begin p 15
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kinetics of SP essential for inducing pathogenic effector memory T cells in mLNs.</bold>
###xml 88 89 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 192 195 192 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 422 423 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 657 658 653 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 734 737 730 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 768 769 764 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 877 878 873 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 975 978 971 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1009 1010 1005 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1118 1119 1114 1115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1200 1203 1196 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1216 1219 1212 1215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1250 1251 1246 1247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1292 1295 1288 1291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 681 696 <span type="species:ncbi:10090">transgenic mice</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
###xml 900 904 <span type="species:ncbi:10090">mice</span>
###xml 979 983 <span type="species:ncbi:10090">mice</span>
###xml 1071 1075 <span type="species:ncbi:10090">mice</span>
###xml 1158 1162 <span type="species:ncbi:10090">mice</span>
###xml 1220 1224 <span type="species:ncbi:10090">mice</span>
###xml 1296 1300 <span type="species:ncbi:10090">mice</span>
Kinetics of SP essential for inducing pathogenic effector memory T cells in mLNs. 5 x 105 cells naive CD8+ T cells from C57BL/6 mice were labeled with CFSE and intravenously injected into RAG2-/- mice. (A) Proliferation of CD8+ T cells was monitored by flow cytometry 3, 5, and 7 d after the injection. The representative FACS profiles are indicated in the figure. (B) CD44 expression and cytokine production levels of CD8+ T cells from pLNs and mLNs in the adoptively transferred mice were examined by staining with mAbs against CD44, IFN-gamma, or IL-17 at day 5. The representative FACS profiles are shown. Percentages are indicated. (C) CFSE-labeled CD8+ T cells from OT-1-TCR transgenic mice were intravenously injected into RAG2-/- mice. Proliferation of the CD8+ T cells in mLNs was analyzed at day 7. The representative FACS profiles are indicated. (D) CFSE-labeled CD8+ T cells from C57BL/6 mice were intravenously injected into untreated and antibiotic-treated RAG2-/- mice. Proliferation of the CD8+ T cells in the mLNs of the untreated and antibiotic-treated mice was analyzed by FACS. (E) CFSE-labeled CD8+ T cells from C57BL/6-background Ly5.1 mice were intravenously injected into RAG2-/- or OT-1/RAG2-/- mice. Proliferation of the CD8+ T cells in the pLNs or mLNs of OT-1/RAG2-/- mice was analyzed by FACS.
###end p 15
###begin title 16
Critical role of IL-6 for SP while inducing pathogenic effector T cells
###end title 16
###begin p 17
###xml 19 21 19 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 88 89 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 250 258 247 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 419 420 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 455 458 449 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 502 505 496 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 523 524 517 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 597 600 591 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 604 605 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 704 705 698 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 740 743 734 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 789 790 783 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 825 828 819 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 966 974 954 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 1152 1160 1137 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 1226 1234 1211 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 1249 1257 1234 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 1354 1362 1335 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 1578 1580 1556 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 1582 1584 1560 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 1638 1639 1616 1617 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 506 511 <span type="species:ncbi:10090">mouse</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
###xml 744 748 <span type="species:ncbi:10090">mice</span>
###xml 829 833 <span type="species:ncbi:10090">mice</span>
###xml 1700 1704 <span type="species:ncbi:10090">mice</span>
In contrast to HP (26), it remains unclear which factors are involved in SP of naive CD8+ T cells in addition to antigen stimulation. We found that mRNA expression levels of IL-6 and TGF-beta were significantly higher in the mLNs compared with pLNs (Fig. 3 A). To evaluate the role for IL-6 and TGF-beta, as well as the homeostatic cytokines IL-7 and IL-15, in SP and HP, we performed the following experiments: (a) CD8+ T cells were transferred into RAG2-/- mice treated with anti-IL-7R mAb; (b) IL-15-/- mouse-derived CD8+ T cells were transferred into IL-15/RAG2 double-knockout mice; (c) IL-15-/- CD8+ T cells were transferred into IL-15/RAG2 double-knockout mice treated with anti-IL-7R mAb; (d) CD8+ T cells were transferred into RAG2-/- mice treated with anti-IL-6R mAb; and (e) CD8+ T cells were transferred into RAG2-/- mice treated with anti-TGF-beta mAb. Neither IL-7, IL-15, nor TGF-beta contributed to SP, whereas IL-7 and/or IL-15 were involved in HP (Fig. 3 B). It was also demonstrated that TGF-beta had no effect on HP (Fig. S2, available at ). Unexpectedly, however, SP was completely blocked by the administration of anti-IL-6R mAb (Fig. 3 C). In contrast, HP was not affected by the anti-IL-6R mAb at all (Fig. 3 C). As shown in Fig. 3 D, both IFN-gamma and IL-17A production were markedly inhibited by treatment with anti-IL-6R mAb (Fig. 3 D). From these findings, IL-6 signaling, but not IL-7, IL-15, or TGF-beta, was considered to be critical for SP in the present model. It has been demonstrated that IL-6 was closely related to the survival of T cells (27, 28). However, there was no significant difference in CD8+ T cell apoptosis between control and anti-IL-6R mAb-treated mice (Fig. S3).
###end p 17
###begin p 18
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Critical role of IL-6 for SP while inducing pathogenic effector T cells.</bold>
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 90 91 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 177 180 177 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 279 282 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 340 341 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 394 397 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 578 579 575 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 616 619 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 771 772 764 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 832 835 825 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 836 840 <span type="species:ncbi:10090">mice</span>
Critical role of IL-6 for SP while inducing pathogenic effector T cells. 5 x 105 naive CD8+ T cells from C57BL/6 mice were labeled with CFSE and intravenously injected into RAG2-/- mice. (A) IL-7, IL-15, IL-6, and TGF-beta mRNA expression levels in pLNs or mLNs of untreated RAG2-/- mice were evaluated by real-time PCR. The means and SDs (n = 4 per group) are indicated. (B) SP in mLNs of RAG2-/- mice treated with anti-IL-7R mAb and RAG2/IL-15 double-knockout mice were observed 7 d after the injection. The representative FACS profiles are indicated. (C) Proliferation of CD8+ T cells in the pLNs and mLNs of RAG2-/- mice treated with anti-IL-6R mAb was observed, and the representative FACS profiles are indicated. (D) Cytokine (IFN-gamma and IL-17) production by CD8+ T cells in the pLNs and mLNs of anti-IL-6R mAb-treated RAG2-/- mice. The representative FACS profiles are shown. Percentages are indicated.
###end p 18
###begin p 19
###xml 16 22 16 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 495 496 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
As described in Fig. 2, we clearly demonstrated that HP and SP of CD8+ T cells were totally distinct in T cell homeostasis, and that SP was not the end stage of HP. We also demonstrated that SP appeared to be triggered with antibiotic-sensitive flora antigen via TCR, consistent with a previous report (29). Therefore, at present, we consider that anti-IL-6R mAb does not affect the apoptosis of HP-related T cells but instead inhibits the SP-related generation of flora-triggered pathogenic CD8+ T cells, which is accelerated in an IL-6-dependent manner. Indeed, IL-6 was demonstrated to promote TCR-mediated T cell proliferation directly (unpublished data).
###end p 19
###begin title 20
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Anti-IL-6R mAb inhibits CD8+ T cell-dependent autoimmune colitis
###end title 20
###begin p 21
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 180 188 180 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 313 328 313 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, B and C</xref>
###xml 617 625 606 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 818 819 807 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
###xml 611 615 <span type="species:ncbi:10090">mice</span>
In vivo injection of anti-IL-6R mAb markedly suppressed the weight loss and abnormal thickening of the large intestine wall, which are associated with CD8+ T cell-induced colitis (Fig. 4 A). HE staining revealed that blockade of IL-6 signaling significantly suppressed cell infiltration into the large intestine (Fig. 4, B and C). Although the mRNA levels of various inflammatory cytokines, including TNF-alpha, IL-1beta, IFN-gamma, and IL-17, were up-regulated in the tissues from the colitis mice, the expression levels in the anti-IL-6R mAb-treated mice were almost the same as those in the untreated normal mice (Fig. 4 D). This evidence demonstrated that IL-6 signaling was not only involved in the up-regulation of inflammatory cytokine levels in the colon tissues but was also related to the pathogenesis of CD8+ T cell-dependent colitis.
###end p 21
###begin p 22
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Anti&#8211;IL-6R mAb inhibits CD8<sup>+</sup> T cell&#8211;dependent autoimmune colitis.</bold>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 205 206 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 227 228 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 247 248 247 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 292 293 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 1092 1096 <span type="species:ncbi:10090">mice</span>
Anti-IL-6R mAb inhibits CD8+ T cell-dependent autoimmune colitis. 5 x 105 naive CD8+ T cells from C57BL/6 mice were intravenously injected into RAG2-/- mice. (A) Body weight of untreated (n = 4), naive CD8+ T cell-transferred (n = 3), or naive CD8+ T cell-transferred/anti-IL-6R mAb-treated (n = 3) mice were monitored for 9 wk. Body weight percentages against the respective preinjection values were calculated every week. The means and SDs are indicated. (B) Colon tissues were obtained from untreated, control, or anti-IL-6R mAb-treated mice 9 wk after the cell transfer. Morphology of the representative colon tissues is shown. Bar, 1 cm. (C) HE staining was performed on the colon tissues from the untreated, control, or anti-IL-6R mAb-treated mice. The representative histological micrographs are shown at two different magnifications. Means and SDs of the colitis score are indicated in the bar graph. Bars: (left) 1 mm; (right) 200 mum. (D) TNF-alpha, IL-1beta, IL-17A, and IFN-gamma mRNA expression levels in the colon tissues from the untreated, control, and anti-IL-6R mAb-treated mice were determined by real-time PCR. The means and SDs are indicated.
###end p 22
###begin title 23
Requirement of Tc17 cells in autoimmune colitis
###end title 23
###begin p 24
###xml 29 31 29 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 32 34 32 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 147 148 147 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 175 178 175 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 365 376 365 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, A&#8211;C</xref>
###xml 525 526 521 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 577 580 573 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 584 585 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 620 623 616 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 630 638 626 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
###xml 672 673 668 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 864 867 856 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 871 872 863 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 907 910 899 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1044 1045 1036 1037 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1201 1202 1189 1190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1359 1367 1343 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 1408 1409 1388 1389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 911 915 <span type="species:ncbi:10090">mice</span>
To define the role of IL-17 (11-14) on the pathogenesis of the CD8+ T cell-mediated autoimmune colitis, we performed adoptive transfer of naive CD8+ T cells derived from IL-17-/- mice. Deficiency of IL-17 in CD8+ T cells caused a remarkable suppression of pathology, including severe weight loss, thickening of the large intestinal wall, and colitogenic responses (Fig. 5, A-C). Thus, we propose that Tc17 cells would be critical effectors in the pathogenesis of autoimmune diseases. The generation of IFN-gamma-producing CD8+ T cells by SP was observed in mLNs even when IL-17-/- CD8+ T cells were transferred into RAG2-/- mice (Fig. 5 D), whereas the infiltration of CD8+ T cells into the colon tissues was greatly inhibited by the IL-17-deficient condition (unpublished data). In addition, we have evidence that this colitis model was not induced when IFN-gamma-/- CD8+ T cells were transferred into RAG2-/- mice, whereas SP of Tc17 cells was generated in mLNs (unpublished data). Therefore, IL-17 was required for the development of the CD8+ T cell-dependent colitis, but IL-17 might synergistically act with IFN-gamma to induce the final colitogenic responses, including migration of effector CD8+ T cells and other inflammatory cells into the colon tissues. We are now investigating the critical role of both IL-17 and IFN-gamma in colitis. As shown in Fig. 3 D, IL-17 and IFN-gamma double-positive CD8+ T cells are rapidly proliferated in mLNs. Therefore, there is a good possibility that SP-induced IL-17 and IFN-gamma double-producing Tc17 cells play a critical role in autoimmune colitis.
###end p 24
###begin p 25
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Requirement of Tc17 cells in autoimmune colitis.</bold>
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 102 105 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 178 179 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 198 199 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 237 240 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 272 273 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 521 522 521 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 552 555 552 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 565 566 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 711 712 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 742 745 742 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 755 756 755 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 933 934 932 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
###xml 776 780 <span type="species:ncbi:10090">mice</span>
###xml 995 999 <span type="species:ncbi:10090">mice</span>
Requirement of Tc17 cells in autoimmune colitis. 5 x 105 naive CD8+ T cells from C57BL/6 WT and IL-17A-/- mice were transferred into RAG2-/- mice. (A) Body weights of untreated (n = 4), WT naive CD8+ T cell-transferred (n = 4), or IL-17A-/- naive CD8+ T cell-transferred (n = 4) mice were monitored for 9 wk after the injection. Body weight percentages against the respective preinjection values were calculated every week. The means and SDs are indicated. (B) Colon tissues were obtained from the untreated, WT naive CD8+ T cell-transferred, or IL-17A-/- naive CD8+ T cell-transferred mice. Morphology of the representative colon tissues is shown. Bar, 1 cm. (C) Colon sections from the untreated, WT naive CD8+ T cell-transferred, or IL-17A-/- naive CD8+ T cell-transferred mice were stained with HE. The representative histological micrographs are shown at two different magnifications. Bars: (left) 1 mm; (right) 200 mum. (D) CD8+ T cells from the pLNs or mLNs of the adoptively transferred mice were intracellularly stained with anti-IFN-gamma mAb and anti-IL-17 mAb. The representative FACS profiles are indicated. Percentages are shown.
###end p 25
###begin p 26
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 98 101 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 380 382 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 478 479 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 506 507 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
We have established a novel model of colitis by transfer of naive CD8+ T cells into syngeneic RAG2-/- mice that mimicked the symptoms of IBD, such as weight loss and excess inflammatory cytokine production. So far, it has been demonstrated that several cytokines, including IL-1beta, TNF-alpha, IFN-gamma, and IL-17, were involved in the induction of inflammation during colitis (30). However, little has been investigated about the physiological role of IL-17 production by CD8+ T cells in contrast to CD4+ T cells. Our results initially demonstrated a pivotal role of Tc17 cells in the pathogenesis of autoimmune colitis.
###end p 26
###begin p 27
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 535 536 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 555 563 555 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
Adoptive transfer of naive CD8+ T cells underwent two distinct types of proliferation, SP and HP. We found that IL-6 signaling was critical for only SP, which was triggered by recognition of antibiotic-sensitive microbe antigens in the gut. The important role of antibiotic-sensitive flora-induced SP was demonstrated from the finding that intestinal flora depletion by antibiotics treatment caused the prevention of weight loss and colitis (unpublished data), in parallel with the blocking of SP, which is essential for pathogenic CD8+ T cell induction (Fig. 2 D). Moreover, IL-6-dependent SP was demonstrated to be critical for the differentiation of the final effector cells, Tc17 cells involved in autoimmune colitis.
###end p 27
###begin p 28
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 217 218 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 300 301 300 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 600 601 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
This report initially proposes a novel mechanism for maintaining the homeostasis of CD8+ T cells, which is triggered under lymphopenic conditions in an IL-6-dependent manner. We designated this phenomenon as SP of CD8+ T cells, which also can be dissociated from IL-6-independent SP of CD4+ T cells (1, 18). Our results also indicate a novel application of anti-IL-6R mAb for the immunotherapy of Tc17 cell-mediated colitis, and propose that the IL-6-dependent SP could be a promising therapeutic target in autoimmune diseases such as IBD. We are now investigating the general role of SP in other CD8+ T cell-mediated immune diseases.
###end p 28
###begin title 29
MATERIALS AND METHODS
###end title 29
###begin title 30
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 30
###begin p 31
###xml 87 90 87 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 386 389 386 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 433 436 433 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 446 449 446 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 454 457 454 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 515 518 515 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 192 207 <span type="species:ncbi:10090">transgenic mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
WT C57BL/6 mice were purchased from Charles River Laboratories. C57BL/6-background RAG2-/- mice were provided by M. Ito (Central Institute for Experimental Animals, Kanagawa, Japan). OT-1-TCR transgenic mice were provided by F.R. Carbone (University of Melbourne, Victoria, Australia). C57BL/6-background Ly5.1 mice were purchased from RIKEN Bioresource Center. C57BL/6-background IL-15-/- mice were purchased from Taconic. OT-1/RAG2-/- and IL-15-/-/RAG2-/- mice were bred in our facility. C57BL/6-background IL-17A-/- mice were established as described previously (14). All mice used in the present studies were 5-8 wk old and maintained in specific pathogen-free conditions according to the guidelines for animal care of our institute. All mice were used in accordance with the guidance of an institutional committee at Hokkaido University.
###end p 31
###begin title 32
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Preparation and adoptive transfer of naive CD8+ T cells.
###end title 32
###begin p 33
###xml 298 299 298 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 521 524 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 529 530 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 540 541 540 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 647 648 647 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 686 687 686 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 706 707 706 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 778 781 778 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
###xml 720 725 <span type="species:ncbi:10090">mouse</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
Total lymphoid cells were recovered from the spleens and pLNs of the mouse strains indicated in the figures and resuspended in RPMI 1640 medium (Sigma-Aldrich) containing 10% FCS (BD Biosciences) plus penicillin and streptomycin (both from Meiji Seika). Erythrocytes were eliminated with 0.155 M NH4Cl. The cells were passed through a nylon wool column for enrichment of T cells and were stained with FITC-CD44 mAb (IM7; eBioscience), PE-CD62L mAb (MEL-14; eBioscience), and PE-Cy7-CD8a mAb (53-6.7; BD Biosciences). CD44lowCD62L+ naive CD8+ T cells were isolated using a cell-sorting system (FACSAria; BD Biosciences). The purity of the naive CD8+ T cells was consistently >98%. 5 x 105 isolated naive CD8+ T cells per mouse were then intravenously injected into syngeneic RAG2-/- mice.
###end p 33
###begin title 34
Induction of experimental colitis.
###end title 34
###begin p 35
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
5 x 105 naive CD8+ T cells were intravenously injected into syngeneic RAG2-/- mice. The body weights of the adoptively transferred mice were monitored for 6-9 wk. The colon tissues were recovered for histopathological analysis and HE staining at the time points indicated in the figures. Clinical scoring was performed as described previously (29). In brief, colitis was graded on a scale of 0-3, as follows: 0, minimal, indistinguishable from normal BALB/c mice; 1, mild; 2, moderate, low to intermediate degree of leukocyte infiltration and epithelial hyperplasia; and 3, severe, extensive leukocyte infiltration, loss of goblet cells, and marked epithelial hyperplasia. Histological evaluation was conducted in a blinded fashion.
###end p 35
###begin title 36
Antibody treatment.
###end title 36
###begin p 37
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 333 338 <span type="species:ncbi:10090">mouse</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 451 456 <span type="species:ncbi:10090">mouse</span>
Mice were intravenously injected with 1-2 mg anti-IL-6R mAb (MR16-1; a gift from Chugai Pharmaceutical Company Ltd., Shizuoka, Japan) at the time of T cell transfer, and were intraperitoneally injected with 500 mug of antibody 4 d after the transfer or every week up to the end of the colitis experiments. 500 mug anti-IL-7R mAb per mouse was intravenously injected before adoptive transfer. The mice were then intraperitoneally injected (500 mug per mouse) on days 2, 4, and 6 after T cell transfer.
###end p 37
###begin title 38
Flow cytometric analysis.
###end title 38
###begin p 39
###xml 798 799 789 790 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
For analysis of cell-surface molecules, the cell samples indicated in the figures were stained with fluorescent dye-conjugated mAbs against the selected markers on ice. Cell proliferation was evaluated by monitoring the fluorescence intensity of the cells prestained with CSFE (Invitrogen), according to the manufacturer's instructions. For detection of cytoplasmic cytokines, the indicated cells were stimulated with anti-CD3epsilon mAb (145-2C11; BD Biosciences) on 96-well flat-bottom plates for 6 h and treated with Brefeldin A for the final 2 h. The stimulated cells were stained with PE-Cy5-TCRbeta mAb (H57-597; BD Biosciences) and fixed with 4% paraformaldehyde phosphate buffer solution (Wako). After treatment with permeabilizing solution (50 mmol/liter NaCl, 5 mmol/liter EDTA, 0.02% NaN3, and 0.5% Triton X-100, pH 7.5), the cells were stained with PE-IL-17 mAb (TC11-18H10.1; BD Biosciences) and allophycocyanin-IFN-gamma mAb (XMG1.2; eBioscience). Fluorescence signals from the cells were acquired by FACSCalibur and analyzed with CellQuest software (both from BD Biosciences). Data were collected with logarithmic amplification.
###end p 39
###begin title 40
ELISA.
###end title 40
###begin p 41
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
Serum KC and SAA levels were determined by the mouse KC ELISA kit (R&D Systems) and the mouse SAA ELISA kit (Invitrogen), respectively. Assays were performed according to the manufacturers' instructions.
###end p 41
###begin title 42
Immunohistochemical staining.
###end title 42
###begin p 43
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 290 295 <span type="species:ncbi:10090">mouse</span>
###xml 398 402 <span type="species:ncbi:9925">goat</span>
###xml 408 411 <span type="species:ncbi:10116">rat</span>
###xml 483 486 <span type="species:ncbi:10116">rat</span>
###xml 492 497 <span type="species:ncbi:10090">mouse</span>
Colons collected from mice were treated with optimum cutting temperature compound (Sakura Finetechnical Co.) and immediately frozen in liquid nitrogen. 4-mum sections of the colon tissues, fixed with acetone at 4degreesC for 10 min followed by blocking for 30 min, were incubated with anti-mouse CD8a mAb (53-6.7). After washing, the sections were further incubated with Alexa Fluor 546-conjugated goat anti-rat IgG (Invitrogen). The serial sections were incubated with biotinylated rat anti-mouse CD11b (M1/70; BD Biosciences), followed by detection with Alexa Fluor 488-conjugated streptavidin (Invitrogen). Each section was incubated with VECTASHIELD (Vector Laboratories) for 30 min, and the immunostaining images were analyzed with a laser scanning microscope (FluoView; Olympus).
###end p 43
###begin title 44
Antibiotics treatment.
###end title 44
###begin p 45
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 267 268 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 278 279 278 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
Drinking water containing 1 g/liter ampicillin sodium (Meiji Seika), 1 g/liter neomycin sulfate (Nacalai Tesque), 500 mg/liter vancomycin (Nacalai Tesque), and 1 g/liter metronidazole (Nacalai Tesque) was provided for RAG2-/- mice at 4 wk before cell transfer. 5 x 105 naive CD8+ T cells stained with CSFE were intravenously injected into the antibiotic-treated mice, and the proliferation was determined by flow cytometry.
###end p 45
###begin title 46
Real-time PCR.
###end title 46
###begin p 47
###xml 1895 1901 1842 1848 <sub xmlns:xlink="http://www.w3.org/1999/xlink">sample</sub>
###xml 1911 1920 1854 1863 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reference</sub>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 455 460 <span type="species:ncbi:10090">mouse</span>
Total RNA was extracted from LNs or colon tissues of the mice indicated in the figures using the Isogen RNA extraction kit (Nippongene), according to the manufacturer's instructions. cDNA was prepared from the total RNA with RT (Invitrogen), oligo dT, and dNTP mixture (Promega). The indicated gene cDNAs were specifically amplified using a thermal cycler system (ABI PRISM 7700 Sequencer; Applied Biosystems) and using the corresponding primer pairs for mouse IL-7, IL-15, IL-6, TGF-beta, IL-1beta, TNF-alpha, IFN-gamma, IL-17A, and beta-actin. The sequences used were as follows: IL-7, (sense) 5'-GAGGTGGGTGTAGTCATGATGACT-3', (antisense) 5'-GGGTCCTGGGAGTGATTATGG-3', and (probe) 5'-AGCCGGCTCCTGCTGCAGTCC-3'; IL-15, (sense) 5'-GACCATGAAGAGGCAGTGCTT-3', (antisense) 5'-CAGCTCAGAGAGGTCAGGAAAGA-3', and (probe) 5'-CCACCTTGACACATGGCCCTCTGG-3'; IL-6, (sense) 5'-GAGGATACCACTCCCAACAGACC-3', (antisense) 5'-AAGTGCATCATCGTTGTTCATACA-3', and (probe) 5'-CAGAATTGCCATTGCACAACTCTTTTCTCA-3'; TGF-beta, (sense) 5'-TGACGTCACTGGAGTTGTACGG-3', (antisense) 5'-GGTTCATGTCATGGATGGTGC-3', and (probe) 5'-TTCAGCGCTCACTGCTCTTGTGACAG-3'; IL-1beta, (sense) 5'-GAAAGACGGCACACCCACC-3', (antisense) 5'-AGACAAACCGCTTTTCCATCTTC-3', and (probe) 5'-TGCAGCTGGAGAGTGTGGATCCCAA-3'; TNF-alpha, (sense) 5'-GTTCTCTTCAAGGGACAAGGCTG-3', (antisense) 5'-TCCTGGTATGAGATAGCAAATCGG-3', and (probe) 5'-TACGTGCTCCTCACCCACACCGTCA-3'; IFN-gamma, (sense) 5'-GGATGCATTCATGAGTATTGC-3', (antisense) 5'-GCTTCCTGAGGCTGGATTC-3', and (probe) 5'-TTTGAGGTCAACAACCCACAGGTCCA-3'; IL-17A, (sense) 5'-GCTCCAGAAGGCCCTCAGA-3', (antisense) 5'-CTTTCCCTCCGCATTGACA-3', (probe) 5'-ACCTCAACCGTTCCACGTCAC-3'; and beta-actin, (sense) 5'-AGCCATGTACGTAGCCATCCA-3', (antisense) 5'-TCTCCGGAGTCCATCACAATG-3', and (probe) 5'-TGTCCCTGTATGCCTCTGGTCGTACCA-3'. Samples were normalized to the housekeeping gene beta-actin according to the DeltaDeltaCt method: DeltaCt = DeltaCtsample - DeltaCtreference. Percentages against the WT control sample were calculated for each sample.
###end p 47
###begin title 48
Statistics.
###end title 48
###begin p 49
###xml 222 223 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
All experiments were repeated at least three times. Mean values and SDs were calculated for data from three independent experiments and are shown in the figures. Statistical significance was calculated using the Student's t test. P < 0.05 was considered significant in the present experiments, as indicated with an asterisk.
###end p 49
###begin title 50
Online supplemental material.
###end title 50
###begin p 51
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 196 197 193 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 296 297 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Fig. S1 demonstrates that injection of anti-IL-6R mAb blocks proliferation of adoptively transferred naive CD8+ T cells in mLNs. Fig. S2 shows that TGF-beta signaling is not required for SP of CD8+ T cells. Fig. S3 demonstrates that anti-IL-6R mAb treatment does not induce apoptosis of naive CD8+ T cells. Online supplemental material is available at .
###end p 51
###begin title 52
Supplementary Material
###end title 52
###begin title 53
[Supplemental Material Index]
###end title 53
###begin p 54
We thank Chugai Pharmaceutical Company Ltd. for their gift of anti-IL-6R antibody (MR16-1). We would like to thank Dr. Mark Micallef for reviewing this paper.
###end p 54
###begin p 55
This work was supported in part by a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology.
###end p 55
###begin p 56
The authors have no conflicting financial interests.
###end p 56

